{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:42:04Z","timestamp":1759693324955,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.mehy.2011.02.030","type":"journal-article","created":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T10:26:01Z","timestamp":1299666361000},"page":"831-833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pediatric cerebellar stroke associated with elevated titer of antibodies to \u03b22-glycoprotein"],"prefix":"10.1016","volume":"76","author":[{"given":"Alberto","family":"Spalice","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Del Balzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco Massimo","family":"Perla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Papetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Nicita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"Ursitti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Properzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2011.02.030_b0005","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1542\/peds.109.1.116","article-title":"Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke","volume":"109","author":"Lynch","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.mehy.2011.02.030_b0010","first-page":"1899","article-title":"Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-\u22772-glycoprotein-I than with antiphospholipid antibodies","volume":"22","author":"Cabiedes","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.mehy.2011.02.030_b0015","first-page":"1894","article-title":"Antibodies to phospholipidfree \u22772-glycoprotein-I in patients with primary antiphospholipid syndrome","volume":"22","author":"Cabral","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.mehy.2011.02.030_b0020","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1212\/WNL.43.10.2069","article-title":"Anticardiolipin antibodies are an independent risk factor for first ischemic stroke","volume":"43","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2011.02.030_b0025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-3476(96)70064-1","article-title":"Clinical characteristics of antiphospholipid antibody syndrome in children","volume":"129","author":"Von Scheven","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.mehy.2011.02.030_b0030","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1542\/peds.94.4.500","article-title":"High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia","volume":"94","author":"Angelini","year":"1994","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.mehy.2011.02.030_b0035","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.mehy.2011.02.030_b0040","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1177\/0961203309106917","article-title":"The Ped-APS Registry: the antiphospholipid syndrome in childhood","volume":"18","author":"Avcin","year":"2009","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.mehy.2011.02.030_b0045","doi-asserted-by":"crossref","first-page":"e1100","DOI":"10.1542\/peds.2008-1209","article-title":"Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry","volume":"122","author":"Avcin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.mehy.2011.02.030_b0050","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0887-8994(94)90068-X","article-title":"Childhood stroke and lupus anticoagulant","volume":"10","author":"Olson","year":"1994","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.mehy.2011.02.030_b0055","first-page":"933","article-title":"Antiphospholipid antibodies and stroke in an infant","volume":"87","author":"Roddy","year":"1991","journal-title":"Pediatrics"},{"key":"10.1016\/j.mehy.2011.02.030_b0060","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/BF01957376","article-title":"Antiphospholipid syndrome in young patients. Two cases of cerebral ischaemic accidents","volume":"154","author":"Di Nucci","year":"1995","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.mehy.2011.02.030_b0065","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/01.STR.31.6.1283","article-title":"Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children","volume":"31","author":"Kenet","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2011.02.030_b0070","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/art.10510","article-title":"Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome","volume":"47","author":"Von Scheven","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.mehy.2011.02.030_b0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1191\/0961203302lu146rr","article-title":"Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations","volume":"11","author":"Avcin","year":"2002","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.mehy.2011.02.030_b0080","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.thromres.2005.09.005","article-title":"Endothelial function is impaired in patients with primary antiphospholipid syndrome","volume":"118","author":"Stalc","year":"2006","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.mehy.2011.02.030_b0085","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/art.22360","article-title":"Antiphospholipid Syndrome and Recurrent Thrombosis in Children Arthritis & Rheumatism","volume":"55","author":"Berkun","year":"2006","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.mehy.2011.02.030_b0090","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0002-9343(99)00053-4","article-title":"Serum anti-\u22772-glycoprotein I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus and the antiphospholipid syndrome","volume":"106","author":"Gomez-Pacheco","year":"1999","journal-title":"Am J Med"},{"issue":"suppl.","key":"10.1016\/j.mehy.2011.02.030_b0095","first-page":"20","article-title":"The antiphospholipid syndrome: immunologic and clinical aspects. Clinical spectrum and treatment","volume":"27","author":"Myones","year":"2000","journal-title":"J Rheumatol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711000818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711000818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:13:04Z","timestamp":1759691584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987711000818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0306987711000818"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2011.02.030","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric cerebellar stroke associated with elevated titer of antibodies to \u03b22-glycoprotein","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2011.02.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}